Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

azacitidine

  • Open Access
    Efficacy of Venetoclax and Azacitidine in Acute Myeloid Leukemia Compared to Azacitidine Monotherapy: Real-World Experience
    YUTA BABA, NORIKO HIDA, TAKEHIKO SAMBE, MAASA ABE, NOBUYUKI KABASAWA, HIROTAKA SAKAI, KIYOSHI YOSHIMURA and TETSUYA FUKUDA
    Anticancer Research May 2024, 44 (5) 2003-2007; DOI: https://doi.org/10.21873/anticanres.17003
  • You have access
    Azacitidine–Hesperetin Combination Induces S-phase Cell Cycle Arrest and Apoptosis in Human Leukemia Cells
    KUAN-MING LAI, RUO-HAN TSENG, YU-HUNG SHIH and YING-CHIH HUANG
    Anticancer Research March 2024, 44 (3) 1033-1044; DOI: https://doi.org/10.21873/anticanres.16898
  • You have access
    Synergistic Antioncogenic Activity of Azacitidine and Curcumin in Myeloid Leukemia Cell Lines and Patient Samples
    IVÁN MARTÍN, BLANCA NAVARRO, CARLOS SOLANO, MARISA CALABUIG, JUAN CARLOS HERNÁNDEZ-BOLUDA, PAULA AMAT, MARÍA JOSÉ REMIGIA, FRANCISCA GARCÍA, EVA VILLAMÓN and MAR TORMO
    Anticancer Research September 2019, 39 (9) 4757-4766; DOI: https://doi.org/10.21873/anticanres.13659
  • You have access
    Impact of Nagasaki Atomic Bomb Exposure on Myelodysplastic Syndrome Patients Who Are Treated with Azacitidine
    TATSURO JO, KENSUKE HORIO and KAZUTO SHIGEMATSU
    Anticancer Research May 2015, 35 (5) 2929-2933;
  • You have access
    Azacitidine in the Front-line Treatment of Therapy-related Myeloid Neoplasms: A Multicenter Case Series
    CARLA MINOIA, NICOLA SGHERZA, GIACOMO LOSETO, GIUSEPPINA GRECO, CATERINA BUQUICCHIO, FRANCESCA MERCHIONNE, CHANDRAKALA TOLDO, IDA GALISE, ANGELA MELPIGNANO, GIUSEPPE TARANTINI, VINCENZO PAVONE and ATTILIO GUARINI
    Anticancer Research January 2015, 35 (1) 461-466;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire